American Medical Systems Receives CE Mark for AdVance(R) Xtra Performance (XP) Male Sling System

MINNETONKA, Minnesota, August 24, 2010 – American Medical Systems(R) (AMS) (Nasdaq: AMMD), a leading provider of
world-class devices and therapies for both male and female pelvic health,
announced today the company received CE (Conformite Europeenne) Mark for
AdVance XP. The device is the latest generation of AMS' AdVance sling, a
minimally invasive implant for the treatment of male [...]

Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan

LONDON, August 24, 2010 – While the penetration of picture archiving and communication systems
(PACS) in European hospitals is 80 per cent, the modern radiology information
system (RIS) that drives PACS has only reached a penetration level of about
41 per cent. Legacy RIS modules ubiquitously dominate the market and many
hospitals are reluctant to install a new [...]

Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors

Rubinfeld expected to assist with FDA approval process for autologous cultured skin substitute, PermaDerm(TM)

NEW YORK, August 24, 2010 – Regenicin, Inc. (www.regenicin.com) (OTC Bulletin Board: WDSTD), a
clinical-stage biotechnology company, announced today that Dr. Joseph
Rubinfeld, one of the four original founders of Amgen, Inc.
(www.amgen.com), has agreed to join the company's board of directors.
Dr. Rubinfeld will [...]

CAS Chemistry Research Report: A Decade Later Human Genome Discoveries Spur Growth of Cancer Treatments

COLUMBUS, Ohio, August 24, 2010 – Today, leukemia patients who have struggled with cancer therapy
resistance and intolerance will now have more options thanks to targeted drug
therapy. Such new treatment options are due, in part, to a rapid increase in
journal and patent publications following the discovery of Gleevec, as
reported by Chemical Abstracts Service (CAS), the [...]

Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives

BEIJING, August 24, 2010 – Cellonis Biotechnologies, a Beijing and HK-based medical research and
application company, has recorded some remarkable results in the treatment of
a twelve-year-old boy with diabetes using their stem cell therapy in a
Beijing partner hospital. He has completely regained his normal life,
enjoying sports and school activities just like every other person his [...]

Isotechnika Pharma and 3SBio Announce Strategic Partnership to Develop and Commercialize Voclosporin in China

EDMONTON, Alberta, August 24, 2010 – Isotechnika Pharma Inc. ("Isotechnika") (TSX: ISA), a biopharmaceutical
company focused on the discovery and development of immune modulating
therapeutics, and 3SBio Inc. ("3SBio") (NASDAQ: SSRX), a leading China-based
biotechnology company focused on researching, developing, manufacturing and
marketing biopharmaceutical products, today announced the signing of a
development and commercialization agreement for voclosporin, a [...]

Pentasa(R) – Shire Receives Ruling From FDA on Citizen’s Petition

DUBLIN and PHILADELPHIA, August 24, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its subsidiary Shire
Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition
relating to Pentasa.

The ruling granted-in-part and denied-in-part the requests from Shire.
Shire had requested the FDA to issue formal [...]